2019-10-08
AskBio has acquired RoverMed BioSciences’ nanotechnology-based drug delivery system to develop its gene therapy platform. RoverMed's nanocapsule technology carries molecules into the nuclei of the targeted cells, which can provide remarkable efficiency and precision targeting. According to the agreement, AskBio will integrate the technology and assume all the assets of RoverMed.
